TrialBioMed research international2017

A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy.

Ryo Kasahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.